Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q48155026)
Watch
English
Chemotherapy in carcinomas of unknown primary site: a high-dose intensity policy.
scientific article
In more languages
default values for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
title
Chemotherapy in carcinomas of unknown primary site: a high-dose intensity policy
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
main subject
chemotherapy
1 reference
based on heuristic
inferred from title
author
Marc Ychou
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
author name string
S Culine
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
M Fabbro
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
G Romieu
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
D Cupissol
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
H Pujol
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
publication date
1 May 1999
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
published in
Annals of Oncology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
volume
10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
issue
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
page(s)
569-575
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
cites work
Cancer of unknown primary site
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1026478009050
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1026478009050
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1026478009050
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reporting results of cancer treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1026478009050
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nonparametric Estimation from Incomplete Observations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1026478009050
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of patients with cancer of an unknown primary site
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1026478009050
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1026478009050
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1026478009050
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1026478009050
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1026478009050
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1023/A:1026478009050
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
PubMed publication ID
10416007
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10416007
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit